high-resolution structure human gpr40 receptor bound allosteric agonist tak- 
human gpr40 receptor hgpr40 also known free fatty-acid receptor ffar1 g-protein-coupled receptor binds long-chain free fatty acids enhance glucose-dependent insulin secretion1 novel treatments type- diabetes mellitus2 therefore possible targeting hgpr40 partial full agonists tak- fasiglifam orally available potent selective partial agonist3 hgpr40 receptor reached phase iii clinical trials potential treatment type- diabetes mellitus4 data clinical studies indicate tak- anago-allosteric modulator hgpr40 ref demonstrates improved glycaemic control low hypoglycaemic risk diabetic patients5 report crystal structure hgpr40 receptor bound tak- angstrom resolution co-complex structure reveals unique binding mode tak- suggests entry non-canonical binding pocket probably occurs via lipid bilayer atomic details extensive charge network ligand binding pocket reveal additional interactions identified previous studies contribute clear understanding tak- binding receptor hgpr40-tak- structure also provides insights plausible binding multiple ligands receptor observed radioligand binding6 ca2+ influx assay studies3 comparison transmembrane helix architecture g-protein-coupled receptors suggests crystallized tak--bound hgpr40 complex inactive-like state 
